Advertisement

Heart and Vessels

, Volume 15, Issue 3, pp 144–146 | Cite as

Plasma brain natriuretic peptide as a parameter to assess efficacy of continuous intravenous infusion of prostacyclin (epoprostenol) to treat severe primary pulmonary hypertension: a case report

  • Michi Wakaumi
  • T. Shiga
  • Katsuhiro Nozaki
  • Katsuhito Fujiu
  • Kazuhiro Shimaya
  • Naoko Ishizuka
  • Naoki Matsuda
  • Hiroshi Kasanuki
CASE REPORT

Abstract

Continuous intravenous infusion of prostacyclin (epoprostenol) as a treatment for primary pulmonary hypertension (PPH) definitely improves the patient's quality of life, but few accurate parameters have been found to evaluate the efficacy of the treatment. We observed a patient with severe PPH whose plasma brain natriuretic peptide (BNP) level changed significantly as her condition and symptoms changed. Plasma BNP may be considered as one of the parameters for assessing the efficacy of prostacyclin treatment.

Key words Pulmonary hypertension Prostacyclin Brain natriuretic peptide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Tokyo 2000

Authors and Affiliations

  • Michi Wakaumi
    • 1
  • T. Shiga
    • 1
  • Katsuhiro Nozaki
    • 1
  • Katsuhito Fujiu
    • 1
  • Kazuhiro Shimaya
    • 1
  • Naoko Ishizuka
    • 1
  • Naoki Matsuda
    • 1
  • Hiroshi Kasanuki
    • 1
  1. 1.Department of CardiologyThe Heart Institute of Japan, Tokyo Women's Medical UniversityTokyoJapan

Personalised recommendations